LNXSF
LANXESS Aktiengesellschaft
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
16.65
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
16.65
Prev close
16.65
Day high
18.11
Day low
18.11
Volume
1
Market cap
—
P/E (TTM)
—
52W range
13.51 – 29.59
Day trading desk
Gap from prior close
+0.00%
Prior close 16.65
VWAP
—
—
Relative volume
—
—
Session range
—
16.65 – 16.65
Position in range
—
—
ATR (14D)
0.03
0.15% of price
Prior day high
16.65
PDH
Prior day low
16.65
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Shares traded
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.06%
-0.7%
1M
-2.06%
-5.8%
3M
-19.95%
-23.0%
6M
-31.93%
-43.0%
YTD
-18.58%
-30.9%
1Y
-42.69%
-62.7%
3Y
-44.59%
-118.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on LNXSF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $5.67B | $6.37B | $6.71B | $8.09B | -10.9% |
| Operating revenue | $5.67B | $6.37B | $6.71B | $8.09B | -10.9% |
| Cost of revenue | $4.54B | $5.07B | $5.45B | $6.15B | -10.4% |
| Gross profit | $1.13B | $1.30B | $1.27B | $1.94B | -12.9% |
| Research & development | $96.00M | $104.00M | $99.00M | $102.00M | -7.7% |
| Selling, general & admin | $1.06B | $1.15B | $1.21B | $1.38B | -7.3% |
| Total operating expense | $1.16B | $1.25B | $1.32B | $1.51B | -6.8% |
| Operating income | -$32.00M | $50.00M | -$50.00M | $426.00M | -164.0% |
| Net interest income | -$8.00M | -$50.00M | -$118.00M | -$28.00M | +84.0% |
| Pre-tax income | -$471.00M | -$197.00M | -$947.00M | $257.00M | -139.1% |
| Tax provision | $105.00M | -$21.00M | -$105.00M | $72.00M | +600.0% |
| Net income | -$577.00M | -$177.00M | $443.00M | $250.00M | -226.0% |
| Net income to common | -$577.00M | -$177.00M | $443.00M | $250.00M | -226.0% |
| Basic EPS | -6.68 | -2.05 | 5.13 | 2.90 | -225.9% |
| Diluted EPS | -6.68 | -2.05 | 5.13 | 2.90 | -225.9% |
| EBIT | -$400.00M | -$121.00M | -$851.00M | $347.00M | -230.6% |
| EBITDA | $406.00M | $445.00M | $145.00M | $893.00M | -8.8% |
| Basic shares | 86.35M | 86.35M | 86.35M | 86.35M | 0.0% |
| Diluted shares | 86.35M | 86.35M | 86.35M | 86.35M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $419.00M | $299.00M | $146.00M | $324.00M | +40.1% |
| Cash & short-term investments | $497.00M | $615.00M | $496.00M | $403.00M | -19.2% |
| Accounts receivable | $520.00M | $650.00M | $613.00M | $858.00M | -20.0% |
| Inventory | $1.22B | $1.35B | $1.36B | $1.86B | -9.4% |
| Total current assets | $2.61B | $3.45B | $2.91B | $4.85B | -24.4% |
| Property, plant & equipment | $2.09B | $2.46B | $2.62B | $2.75B | -14.9% |
| Goodwill & intangibles | $2.11B | $2.53B | $2.72B | $3.33B | -16.7% |
| Total assets | $7.75B | $9.71B | $9.66B | $11.29B | -20.2% |
| Total current liabilities | $1.56B | $1.77B | $1.17B | $2.43B | -12.0% |
| Current debt | $512.00M | $521.00M | $18.00M | $770.00M | -1.7% |
| Long-term debt | $1.79B | $2.29B | $2.78B | $3.27B | -21.6% |
| Total debt | $2.47B | $3.00B | $3.00B | $4.23B | -17.7% |
| Total liabilities | $4.25B | $5.12B | $5.16B | $6.86B | -17.0% |
| Retained earnings | -$577.00M | -$177.00M | $443.00M | $250.00M | -226.0% |
| Shareholder equity | $3.50B | $4.59B | $4.50B | $4.42B | -23.8% |
| Working capital | $1.05B | $1.68B | $1.74B | $2.42B | -37.6% |
| Net tangible assets | $1.39B | $2.06B | $1.78B | $1.09B | -32.5% |
| Shares issued | 86.35M | 86.35M | 86.35M | 86.35M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$471.00M | -$197.00M | -$947.00M | $257.00M | — | -139.1% |
| Depreciation & amortisation | $806.00M | $566.00M | $996.00M | $546.00M | — | +42.4% |
| Change in working capital | -$80.00M | $38.00M | $594.00M | -$631.00M | — | -310.5% |
| Operating cash flow | $289.00M | $508.00M | $838.00M | $159.00M | — | -43.1% |
| Capital expenditure | -$319.00M | -$320.00M | -$326.00M | -$407.00M | — | +0.3% |
| Investing cash flow | $404.00M | -$263.00M | $423.00M | -$1.05B | — | +253.6% |
| Share buybacks | — | — | — | — | $0 | — |
| Dividends paid | -$10.00M | -$9.00M | -$91.00M | -$91.00M | — | -11.1% |
| Financing cash flow | -$559.00M | -$97.00M | -$1.47B | $613.00M | — | -476.3% |
| Free cash flow | -$30.00M | $188.00M | $512.00M | -$248.00M | — | -116.0% |
| End cash position | $419.00M | $299.00M | $146.00M | $360.00M | — | +40.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.56B | $1.38B | $1.27B | $1.34B | $1.47B | +13.3% |
| Operating revenue | $1.56B | $1.38B | $1.27B | $1.34B | $1.47B | +13.3% |
| Cost of revenue | $1.23B | $1.12B | $1.04B | $1.08B | $1.14B | +10.3% |
| Gross profit | $330.00M | $262.00M | $228.00M | $254.00M | $327.00M | +26.0% |
| Research & development | $24.00M | $26.00M | $21.00M | $22.00M | $24.00M | -7.7% |
| Selling, general & admin | $276.00M | $264.00M | $250.00M | $243.00M | $281.00M | +4.5% |
| Total operating expense | $357.00M | $302.00M | $180.00M | $282.00M | $356.00M | +18.2% |
| Operating income | -$27.00M | -$40.00M | $48.00M | -$28.00M | -$29.00M | +32.5% |
| Net interest income | $12.00M | -$32.00M | $5.00M | -$8.00M | $2.00M | +137.5% |
| Pre-tax income | -$46.00M | -$136.00M | -$287.00M | -$68.00M | -$55.00M | +66.2% |
| Tax provision | $6.00M | $5.00M | $111.00M | $8.00M | -$10.00M | +20.0% |
| Net income | -$53.00M | -$141.00M | -$398.00M | -$77.00M | -$45.00M | +62.4% |
| Net income to common | -$53.00M | -$141.00M | -$398.00M | -$77.00M | -$45.00M | +62.4% |
| Basic EPS | -0.62 | -1.63 | -4.61 | -0.89 | -0.52 | +62.0% |
| Diluted EPS | -0.62 | -1.63 | -4.61 | -0.89 | -0.52 | +62.0% |
| EBIT | -$36.00M | -$125.00M | -$247.00M | -$59.00M | -$45.00M | +71.2% |
| EBITDA | $96.00M | -$4.00M | $74.00M | $74.00M | $172.00M | +2,500.0% |
| Basic shares | 86.35M | 86.35M | 86.33M | 86.35M | 86.35M | 0.0% |
| Diluted shares | 86.35M | 86.35M | 86.33M | 86.35M | 86.35M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $529.00M | $399.00M | $419.00M | $329.00M | $323.00M | — | +32.6% |
| Cash & short-term investments | $1.07B | $569.00M | $497.00M | $606.00M | $625.00M | — | +88.8% |
| Accounts receivable | $708.00M | $623.00M | $520.00M | $527.00M | $615.00M | — | +13.6% |
| Inventory | $1.33B | $1.28B | $1.22B | $1.36B | $1.36B | — | +3.6% |
| Total current assets | $3.32B | $2.68B | $2.61B | $2.70B | $2.81B | — | +24.0% |
| Property, plant & equipment | $2.05B | $2.08B | $2.09B | $2.15B | $2.20B | — | -1.2% |
| Goodwill & intangibles | $2.10B | $2.12B | $2.11B | $2.22B | $2.25B | — | -0.6% |
| Total assets | $8.35B | $7.75B | $7.75B | $8.18B | $8.43B | — | +7.8% |
| Total current liabilities | $1.84B | $1.59B | $1.56B | $1.03B | $1.17B | — | +15.6% |
| Current debt | — | — | $512.00M | — | — | $521.00M | — |
| Long-term debt | — | — | $1.79B | — | — | $2.29B | — |
| Total debt | — | — | $2.47B | — | — | $3.00B | — |
| Total liabilities | $4.87B | $4.25B | $4.25B | $4.28B | $4.43B | — | +14.5% |
| Retained earnings | -$194.00M | -$141.00M | -$577.00M | -$179.00M | -$102.00M | — | -37.6% |
| Shareholder equity | $3.48B | $3.49B | $3.50B | $3.90B | $3.99B | — | -0.4% |
| Working capital | $1.48B | $1.08B | $1.05B | $1.66B | $1.64B | — | +36.3% |
| Net tangible assets | $1.38B | $1.38B | $1.39B | $1.69B | $1.74B | — | -0.2% |
| Shares issued | 86.35M | 86.35M | 86.35M | 86.35M | 86.35M | — | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$46.00M | -$136.00M | -$287.00M | -$68.00M | -$55.00M | — | +66.2% |
| Depreciation & amortisation | $132.00M | $121.00M | $321.00M | $133.00M | $217.00M | — | +9.1% |
| Change in working capital | $32.00M | -$69.00M | $128.00M | -$38.00M | $13.00M | — | +146.4% |
| Operating cash flow | $120.00M | $12.00M | $209.00M | $50.00M | $96.00M | — | +900.0% |
| Capital expenditure | -$64.00M | -$41.00M | -$145.00M | -$64.00M | -$65.00M | — | -56.1% |
| Investing cash flow | -$434.00M | $24.00M | -$151.00M | -$13.00M | $475.00M | — | -1,908.3% |
| Dividends paid | -$9.00M | — | $0 | — | -$10.00M | $0 | — |
| Financing cash flow | $444.00M | -$57.00M | $33.00M | -$29.00M | -$535.00M | — | +878.9% |
| Free cash flow | $56.00M | -$29.00M | $64.00M | -$14.00M | $31.00M | — | +293.1% |
| End cash position | $529.00M | $399.00M | $419.00M | $329.00M | $323.00M | — | +32.6% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
16.91
-1.54% from price
SMA 20
16.95
-1.80% from price
SMA 50
17.04
-2.30% from price
SMA 100
18.95
-12.13% from price
SMA 200
19.50
-14.59% from price
EMA 12
16.88
-1.36% from price
EMA 26
17.02
-2.16% from price
EMA 50
17.45
-4.58% from price
RSI (14)
1.6
Oversold
MACD (12,26,9)
-0.14
Hist -0.00
ATR (14)
0.03
0.15% of price
Realised vol 30D
4.2%
Annualised
Bollinger upper
17.18
20, 2σ
Bollinger lower
16.73
20, 2σ
50 / 200 cross
Death
17.04 vs 19.50
Trend bias
Below 200
-14.59%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.28
Less volatile than market
Correlation to SPY
0.06
Largely independent
Realised vol 30D
4.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-54.3%
Peak to trough
Max drawdown 5Y
-82.4%
Peak to trough
ATR 14
0.03
0.15% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Following Wynca Group and Hubei Xingfa's Expansion in IDA-Based Synthesis Routes, New Study Projects $1.1 Billion Phosphorus Trichloride Market for Glyphosate
GlobeNewswire · 9d ago
Aniline and p-Nitrophenol from Pesticide Synthesis Market Forecast 2026-2035 Now Available — Forecasts $480M to $754M, Profiles BASF, Lanxess, Sumitomo, and 12 Other Key Players
GlobeNewswire · 13d ago
Basic Materials Roundup: Market Talk
The Wall Street Journal · 16d ago
Lanxess AG (LNXSF) (Q2 2026) Earnings Call Highlights: Operational Turning Point Drives ...
GuruFocus.com · 16d ago
LANXESS Aktiengesellschaft Q2 Earnings Call Highlights
MarketBeat · 16d ago
Chromium Salt Market Size, Share & Trends Analysis Report, 2026-2033 Published — 85-Page Study Profiling BASF, Lanxess, and 8 Other Key Players
GlobeNewswire · 23d ago
[Latest] Global Specialty Chemicals Market Size/Share Worth USD 1497 Billion by 2035 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire · 89d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.